These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38681476)

  • 21. Pseudohypoaldosteronism associated with hypertrophic cardiomyopathy, hypertension and thrombocytosis due to mutation in the ELAC2 gene: a case report.
    Mendes LC; de Oliveira Magalhães R; Pereira Dos Santos RK; Araújo RS
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1437-1442. PubMed ID: 35946480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1.
    Ekinci Z; Aytac MB; Cheong HI
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1197-200. PubMed ID: 23813355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1.
    Dirlewanger M; Huser D; Zennaro MC; Girardin E; Schild L; Schwitzgebel VM
    Am J Physiol Endocrinol Metab; 2011 Sep; 301(3):E467-73. PubMed ID: 21653223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neonatal systemic pseudohypoaldosteronism type I].
    Cao XC; Chen YY; Zhang K; Zhang XJ; Yang L; Li ZH
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):774-778. PubMed ID: 37529962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Neonate with Autosomal Dominant Pseudohypoaldosteronism Type 1 Due to a Novel Microdeletion of the
    Kim SJ; Park D; Jang W; Lee J
    Children (Basel); 2021 Nov; 8(12):. PubMed ID: 34943285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compound heterozygous mutations in the gamma subunit gene of ENaC (1627delG and 1570-1G-->A) in one sporadic Japanese patient with a systemic form of pseudohypoaldosteronism type 1.
    Adachi M; Tachibana K; Asakura Y; Abe S; Nakae J; Tajima T; Fujieda K
    J Clin Endocrinol Metab; 2001 Jan; 86(1):9-12. PubMed ID: 11231969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism.
    Nozu K; Fu XJ; Kaito H; Kanda K; Yokoyama N; Przybyslaw Krol R; Nakajima T; Kajiyama M; Iijima K; Matsuo M
    Pediatr Nephrol; 2007 Aug; 22(8):1219-23. PubMed ID: 17401586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Management in Systemic Type Pseudohypoaldosteronism Due to
    Karacan Küçükali G; Çetinkaya S; Tunç G; Oğuz MM; Çelik N; Akkaş KY; Şenel S; Güleray Lafcı N; Savaş Erdeve Ş
    J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):446-451. PubMed ID: 32840096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure to Thrive, Hyponatremia, Hyperkalemia - Differential Diagnostic Reflections of a Rare Genetic Disease.
    Tropschuh A; de Potzolli B; Seeliger S
    Klin Padiatr; 2020 Jan; 232(1):29-32. PubMed ID: 31914462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mild and transient form of autosomal recessive pseudohypoaldosteronism type 1 caused by a novel mutation in the
    Efthymiadou A; Gautschi I; van Bemmelen MX; Sertedaki A; Giannakopoulos A; Chrousos G; Schild L; Chrysis D
    Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E1-E9. PubMed ID: 37134141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.
    Alkhatib EH; Bartlett D; Kanakatti Shankar R; Regier D; Merchant N
    Front Endocrinol (Lausanne); 2023; 14():1297335. PubMed ID: 38288475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular and skin manifestations in systemic pseudohypoaldosteronism.
    Eliwa MS; El-Emmawie AH; Saeed MA
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24654255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia.
    Tuhan HU; Catli G; Anik A; Onay H; Dundar B; Bober E; Abaci A
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):701-4. PubMed ID: 25503463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudohypoaldosteronism types I and II: little more than a name in common.
    Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
    J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
    Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
    Zennaro MC; Fernandes-Rosa F
    J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.